The antidepressant -like effects of delta-opioid receptor agonists
about
Biomarkers of epileptogenesis: psychiatric comorbidities (?)The atypical antidepressant and neurorestorative agent tianeptine is a μ-opioid receptor agonistNovel sigma (sigma) receptor agonists produce antidepressant-like effects in miceCommon Mechanisms Underlying Epileptogenesis and the Comorbidities of Epilepsy.Discovery, synthesis, and molecular pharmacology of selective positive allosteric modulators of the δ-opioid receptor.Salvinorin A analogs as probes in opioid pharmacology.Metabolic changes in the rodent brain after acute administration of salvinorin A.Identification of the First Marine-Derived Opioid Receptor "Balanced" Agonist with a Signaling Profile That Resembles the EndorphinsFurther studies on lead compounds containing the opioid pharmacophore Dmt-Tic.Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.β-arrestin-2-biased agonism of delta opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) in primary sensory neurons.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.In vivo properties of KNT-127, a novel δ opioid receptor agonist: receptor internalization, antihyperalgesia and antidepressant effects in mice.Endogenous opioids as physiological antidepressants: complementary role of δ receptors and dopamine.Inflammatory pain is enhanced in delta opioid receptor-knockout miceCocaine withdrawal-induced anxiety in females: impact of circulating estrogen and potential use of delta-opioid receptor agonists for treatment.NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action.Antidepressant-like Effects of δ Opioid Receptor Agonists in Animal ModelsEffects of the δ opioid receptor agonist SNC80 on pain-related depression of intracranial self-stimulation (ICSS) in rats.In vitro and in vivo pharmacological profile of UFP-512, a novel selective delta-opioid receptor agonist; correlations between desensitization and tolerance.Case-control association analysis of polymorphisms in the δ-opioid receptor, OPRD1, with cocaine and opioid addicted populationsDelta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches.Opioid Peptides: Potential for Drug Development.Role of benzimidazole (Bid) in the delta-opioid agonist pseudopeptide H-Dmt-Tic-NH-CH(2)-Bid (UFP-502)Cocaine withdrawal-induced trafficking of delta-opioid receptors in rat nucleus accumbensDiscovery of Potent and Selective Agonists of δ Opioid Receptor by Revisiting the "Message-Address" ConceptSynthesis of a potent and selective (18)F-labeled delta-opioid receptor antagonist derived from the Dmt-Tic pharmacophore for positron emission tomography imaging.Opioid receptors: from binding sites to visible molecules in vivo.A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.A role for delta opioid receptors in the central nucleus of the amygdala in anxiety-like behaviors.Management of chronic noncancer pain in depressed patients.Emerging drugs for major depressive disorder.Non-peptidic δ opioid receptor agonists and antagonists (2000 - 2012).Delta opioid agonists: a concise update on potential therapeutic applications.Allostery at opioid receptors: modulation with small molecule ligands.Physiologically based pharmacokinetic modeling to predict complex drug-drug interactions: a case study of AZD2327 and its metabolite, competitive and time-dependent CYP3A inhibitors.Pharmacokinetics, metabolism and excretion of [(14)C]-lanicemine (AZD6765), a novel low-trapping N-methyl-d-aspartic acid receptor channel blocker, in healthy subjects.Antidepressant-like and anxiolytic-like effects following activation of the μ-δ opioid receptor heteromer in the nucleus accumbens.Cooperative opioid and serotonergic mechanisms generate superior antidepressant-like effects in a mice model of depression.The opioid receptor triple agonist DPI-125 produces analgesia with less respiratory depression and reduced abuse liability.
P2860
Q27015612-D5A1DCF6-B496-4A46-B1A0-7FFA9D2C7EAEQ28243936-A25F9E27-FE14-43B6-BD8B-B3304184A0DCQ28294148-918A3017-8EA6-4580-A8BF-E8BBF00798C2Q30249189-7728F52A-E70D-4B63-9CD3-676B4E00E169Q30394379-F1A5D4C2-15AB-49F0-92CA-3EE3DEC15431Q30439719-6B453D15-3762-45C5-93BF-BE4EF0FEFB87Q30490227-026B4509-804C-4C6A-B598-A1F697FACB5EQ30841944-8BEB3C4A-6678-45D2-905F-2AE4686EF013Q33613159-E5A8683B-73EC-4548-BD67-40D05F783156Q33815047-426FC488-F229-425E-9BDD-E33122338366Q34039598-31BF7707-C4D2-4EB1-BC82-4F9E74C2E144Q34766451-E0D3F575-0091-4C21-A106-7243F631CB3EQ34953409-5AAC19FA-A39B-4CA7-9E3D-08848D6F66A7Q35614170-B3DD3625-1140-4A2E-9937-6F2FEADE44E1Q35653788-142BB00B-E41C-49A8-9DB2-84AA0ABCADB3Q35793130-36F79577-17F7-40DD-B814-E7FE701BDD65Q35924672-8062D52E-7A78-4FDF-8003-92970A6C5C28Q36310509-16EF0B19-27B8-4B5D-9B76-046C9EEB0220Q36333358-7531D975-DCD4-4AE6-A452-B220C405939CQ36358677-049E6D91-3F02-4C69-9A75-EFAB18FC1CA2Q36431241-1A8C9FB0-7955-4751-956A-A1D92F6B9538Q36438816-5FC4A115-26F3-4AC0-BC05-260C502D7B8BQ36517233-75A9F740-0F71-495D-A96A-6DE84BC73A44Q36666706-A3D3026A-C48C-41DF-A7B1-4791A865EE27Q36776058-D060E133-D76C-4C3C-91B3-31399E91561DQ36806783-F6628C76-7C5C-4693-95C8-CF3D01FBB2ADQ37153933-67B1F6B9-DC88-4E27-B46E-25F723D81F66Q37249017-72595AC4-D00F-4DB5-9011-62C4800E9187Q37405727-7E0466DE-861F-4F87-B71D-FA86155997D4Q37708449-368177A3-4461-4A5E-BCBF-404BC38EF236Q37929505-E28D4598-46F5-4202-84BB-040040D3C2E1Q37984619-2741C176-A4E0-4058-8FFC-E3E758DF0511Q38109239-55E6B419-F0C7-4ACE-8321-F9BC590CD3AAQ38366279-079A6CF3-4DB1-45E9-8070-EBC59234EAFCQ39248479-F4EF1890-2F89-43D2-954A-C079FA5E6C2AQ40829831-FE3C55A2-5D12-467B-A56B-4CD134FA2412Q41725208-07490EA4-F525-4496-A808-6F2F6C2B9156Q44341273-7562BFB0-E35F-4932-91C7-15FFF4AE5A19Q44342182-37A25703-4BC6-426F-8464-93DB816A6FFFQ44345635-EB1FC114-B7DE-4E43-AFF9-BC2FB5599741
P2860
The antidepressant -like effects of delta-opioid receptor agonists
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The antidepressant -like effects of delta-opioid receptor agonists
@ast
The antidepressant -like effects of delta-opioid receptor agonists
@en
The antidepressant -like effects of delta-opioid receptor agonists
@nl
type
label
The antidepressant -like effects of delta-opioid receptor agonists
@ast
The antidepressant -like effects of delta-opioid receptor agonists
@en
The antidepressant -like effects of delta-opioid receptor agonists
@nl
prefLabel
The antidepressant -like effects of delta-opioid receptor agonists
@ast
The antidepressant -like effects of delta-opioid receptor agonists
@en
The antidepressant -like effects of delta-opioid receptor agonists
@nl
P356
P1476
The antidepressant -like effects of delta-opioid receptor agonists
@en
P2093
Emily M Jutkiewicz
P356
10.1124/MI.6.3.7
P407
P577
2006-06-01T00:00:00Z